Strain or plasmid | Genotype or description | References or source |
---|---|---|
Strains | ||
B. cepacia LMG18821 | Cystic fibrosis clinical isolate (Australia), MLST ST5 | Mahenthiralingam et al. (2000) |
B. contaminans IST408 | Cystic fibrosis clinical isolate (Portugal), MLST ST96 | Richau et al. (2000) |
B. multivorans LMG16660 | Govan C1576, Cystic fibrosis clinical isolate (UK), Glasgow epidemic reference, MLST ST27 | Mahenthiralingam et al. (2000) |
B. multivorans LMG18825 | Ryley CF-A1-1, Cystic fibrosis clinical isolate (UK), South Wales outbreak, MLST ST15 | Mahenthiralingam et al. (2000) |
B. cenocepacia LMG16656 | Govan J2315, Cystic fibrosis clinical isolate (UK), ET12 lineage reference strain, genome sequenced, MLST ST28 | Govan and Deretic (1996) |
B. cenocepacia R-1448 | Cystic fibrosis clinical isolate (Canada) | Mil-Homens et al. (2010) |
B. cenocepacia LMG18829 | Speert PC184, Cystic fibrosis clinical isolate (USA), Midwest strain, MLST ST40 | Mahenthiralingam et al. (2000) |
B. cenocepacia R-4194 | Cystic fibrosis clinical isolate | Mil-Homens et al. (2010) |
B. cenocepacia LMG16654 | Govan J415; Cystic fibrosis clinical isolate (UK), MLST ST34 | Mahenthiralingam et al. (2000) |
B. stabilis LMG14294 | Cystic fibrosis clinical isolate (Belgium), MLST ST50 | Mahenthiralingam et al. (2000) |
B. vietnamiensis R-5143 | Cystic fibrosis clinical isolate | Prof. Gerd Döring |
B. dolosa LMG18944 | LiPuma PC688, Cystic fibrosis clinical isolate (USA) | Coenye et al. (2001) |
Escherichia coli DH5α | F− endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169, hsdR17(r −K m +K ), λ– | Invitrogen |
E. coli BL21 (DE3) | F− ompT hsdSB (r −B m −B ) dcm gal λ(DE3). | Stratagene |
Plasmids | ||
pET23a+ | Cloning/expression vector, T7 promoter, C-terminal 6× His-Tag, Apr | Novagen |
pSAS6 | pET23a+ with BCAL2958 gene cloned downstream of T7 promoter | This study |